A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor

Area of Science:

• Organic Chemistry
• Biochemistry
• Enzyme Inhibition

Background:

• Sphingosine-1-phosphate (S1P) is a key bioactive lipid mediator.
• Sphingosine-1-phosphate lyase (S1PL) regulates S1P levels.
• Developing specific S1PL inhibitors is crucial for therapeutic intervention.

Purpose of the Study:

• To synthesize novel vinylated analogues of sphingosine-1-phosphate.
• To investigate their inhibitory potential against human sphingosine-1-phosphate lyase (hS1PL).
• To characterize the mechanism of inhibition for promising candidates.

Main Methods:

• Chemical synthesis of vinylated S1P analogues.
• Configurational assignment using Vacuum Circular Dichroism (VCD) methods.
• Enzyme inhibition assays using recombinant human S1PL.

Main Results:

• Successful synthesis of a series of vinylated S1P analogues.
• Compound RBM10-8 demonstrated irreversible inhibition of hS1PL.
• RBM10-8 also functioned as a substrate for hS1PL.
• A mechanism-based inhibition was proposed for RBM10-8.

Conclusions:

• The synthesized vinylated analogues represent a new class of S1PL modulators.
• RBM10-8 is identified as a novel mechanism-based inhibitor and substrate of hS1PL.
• These findings provide insights into S1PL enzymatic activity and inhibitor design.